BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31348483)

  • 1. Mixed copper(ii)-phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response.
    Moráň L; Pivetta T; Masuri S; Vašíčková K; Walter F; Prehn J; Elkalaf M; Trnka J; Havel J; Vaňhara P
    Metallomics; 2019 Sep; 11(9):1481-1489. PubMed ID: 31348483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
    Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
    J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic property, DFT calculation, and biological activity of bis[(μ(2)-chloro)chloro(1,10-phenanthroline)copper(II)] complex.
    Mroueh M; Daher C; Hariri E; Demirdjian S; Isber S; Choi ES; Mirtamizdoust B; Hammud HH
    Chem Biol Interact; 2015 Apr; 231():53-60. PubMed ID: 25753321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective Cu
    Machado PHA; Paixão DA; Lino RC; de Souza TR; de Souza Bontempo NJ; Sousa LM; Van Petten de Vasconcelos Azevedo F; Orsolin PC; Lima PMAP; Martins IC; da Costa Guerra JF; Teixeira SC; Araújo TG; Goulart LR; Morelli S; Guerra W; de Oliveira Júnior RJ
    Sci Rep; 2021 Dec; 11(1):24450. PubMed ID: 34961767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New water-soluble copper (II) complexes including 4,7-dimethyl-1,10-phenanthroline and L-tyrosine: synthesis, characterization, DNA interactions and cytotoxicities.
    İnci D; Aydın R; Yılmaz D; Gençkal HM; Vatan Ö; Çinkılıç N; Zorlu Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():761-70. PubMed ID: 25448975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.
    Masuri S; Vaňhara P; Cabiddu MG; Moráň L; Havel J; Cadoni E; Pivetta T
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new copper(II) complex containing long-chain aliphatic hydrazide and 1,10-phenanthroline upregulates ADP hydrolysis in triple-negative breast cancer cells.
    Ferreira HSV; Ramos LMS; Silva FC; Alves DL; de Menezes Pereira G; de Oliveira Santiago PH; de Almeida AM; Ellena J; Corbi PP; Oliveira CG; de Almeida MV; Fürstenau CR; Borges DS; Siqueira RP; Guerra W; Araújo TG
    J Inorg Biochem; 2024 Jun; 255():112524. PubMed ID: 38507993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
    Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
    Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
    J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper(II) Complexes of Phenanthroline and Histidine Containing Ligands: Synthesis, Characterization and Evaluation of their DNA Cleavage and Cytotoxic Activity.
    Leite SM; Lima LM; Gama S; Mendes F; Orio M; Bento I; Paulo A; Delgado R; Iranzo O
    Inorg Chem; 2016 Nov; 55(22):11801-11814. PubMed ID: 27934321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the tetravanadate [V
    Sánchez-Lara E; Favela R; Tzian K; Monroy-Torres B; Romo-Pérez A; Ramírez-Apan MT; Flores-Alamo M; Rodríguez-Diéguez A; Cepeda J; Castillo I
    J Biol Inorg Chem; 2024 Feb; 29(1):139-158. PubMed ID: 38175299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
    Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
    J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
    Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
    J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
    Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
    J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-L-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes.
    Alvarez N; Leite CM; Napoleone A; Mendes LFS; Fernández CY; Ribeiro RR; Ellena J; Batista AA; Costa-Filho AJ; Facchin G
    J Biol Inorg Chem; 2022 Aug; 27(4-5):431-441. PubMed ID: 35524804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bulk Breast Cancer Cell and Breast Cancer Stem Cell Activity of Binuclear Copper(II)-Phenanthroline Complexes.
    Osei PB; Northcote-Smith J; Fang J; Singh K; Ortu F; Suntharalingam K
    Chemistry; 2023 Aug; 29(45):e202301188. PubMed ID: 37249243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.